Toronto: Pioglitazone, a drug commonly prescribed for type 2 diabetes, may also elevate bladder cancer risk, says a new Canadian research.In a bid to link pioglitazone and bladder cancer, researchers conducted a systematic review and analysis of clinical trials and observational studies involving over 2.6 million patients."We observed an increased risk of bladder cancer associated with the use of thiazolidinediones," writes Jeffrey Johnson from the School of Public Health, University of Alberta and study co-author, the Canadian Medical Association Journal reports.Thiazolidinediones, including Pioglitazone, introduced in the late 1990s, are also known as glitazones, a class of drugs used in the treatment of type 2 diabetes, according to an Alberta statement.
Chhattisgarh: 20 jawans feared dead in Naxal attack
Gujarat is shining for industrialists: Rahul Gandhi
Modi slams Nitish Kumar in Bihar rally
AAP leader Ashwin Upadhyay calls Arvind Kejriwal `CIA agent`